91 Results

People

  1. Motzer
    Motzer
  2. Makker
    Makker
  3. Abou-Alfa
    Abou-Alfa
  4. Drilon
    Drilon
  5. Lee
    Lee
  6. Voss
    Voss
  7. Wong
    Wong
  8. Aghajanian
    Aghajanian
  9. Carlo
    Carlo
  10. Konner
    Konner

Groups

  1. Department of Medicine (72)
  2. Solid Tumor Oncology Division (70)
  3. Genitourinary Oncology Service (30)
  4. GDMT, Medicine (18)
  5. Gynecologic Medicine Service (18)
  6. Gynecology Disease Management Team (18)
  7. Radiology, Department of (12)
  8. Gastrointestinal Oncology Service (11)
  9. Center for Pancreatic Cancer Research (9)
  10. Weinberg Fellows (9)
  1. "lenvatinib"
Formats
  1. Journal Article (58)
  2. Review (19)
  3. Editorial (3)
  4. Guidelines (3)
  5. Research Letter (3)
  6. Correspondence (2)
  7. Meeting Abstract (2)
  8. Book Section (1)
Groups
  1. Department of Medicine (72)
  2. Solid Tumor Oncology Division (70)
  3. Genitourinary Oncology Service (30)
  4. GDMT, Medicine (18)
  5. Gynecologic Medicine Service (18)
  6. Gynecology Disease Management Team (18)

More Groups

People
  1. Robert Motzer (25)
  2. Vicky Makker (16)
  3. Ghassan Abou-Alfa (9)
  4. Chung-Han Lee (7)
  5. Alexander Drilon (4)
  6. Martin Voss (4)

More People

Years
  1. 2025 (9)
  2. 2024 (18)
  3. 2023 (18)
  4. 2022 (12)
  5. 2021 (11)
  6. 2020 (9)

More Years

Publications
  1. European Urology (5)
  2. Cancers (4)
  3. The Oncologist (4)
  4. Annals of Oncology (3)
  5. Journal of Clinical Oncology (3)
  6. Journal of Gastrointestinal Oncology (3)

More Publications

Publishers
  1. Elsevier Inc. (16)
  2. Elsevier Science, Inc. (8)
  3. Oxford University Press (8)
  4. MDPI (4)
  5. Nature Publishing Group (4)
  6. Wiley Blackwell (4)

More Publishers

Results (91)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1/2 study of lenvatinib in combination with everolimus in recurrent and refractory pediatric and young adult solid tumors
    Journal Article

    Dela Cruz, F. S.; Fox, E.; DuBois, S. G.; Friedman, G. K.; Croop, J. M.; Kim, A.; Morgenstern, D. A.; Balis, F. M.; Macy, M. E.; Pressey, J. G.; more...
    Pediatric Blood and Cancer (2025)

    Fulltext@MSK | Save
  • Top advances of the year: Neoadjuvant immunotherapy in melanoma
    Editorial

    Chen, M. F.; Postow, M. A.
    Cancer (2025)

    Fulltext@MSK | Save
  • Treatment holidays in patients with Erdheim-Chester disease receiving vemurafenib: A prospective pilot study
    Research Letter

    Pegoraro, F.; Catamerò, F.; Allegretta, F.; Palazzini, G.; Peyronel, F.; Diamond, E. L.; Vaglio, A.
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Biomarker analyses from the phase III randomized CLEAR trial: Lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinoma
    Journal Article

    Motzer, R. J.; Porta, C.; Eto, M.; Hutson, T. E.; Rha, S. Y.; Merchan, J. R.; Winquist, E.; Gurney, H.; Grünwald, V.; George, S.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • TIP25-243: Randomized study evaluating optimal dose, efficacy and safety of E7386 + lenvatinib versus treatment of physicians' choice in advance/recurrent endometrial carcinoma previously treated with anti-PD-(L)1 immunotherapy
    Meeting Abstract

    Eskander, R.; Lee, J. Y.; Mirza, M.; Lorusso, D.; Mackay, H.; Ray-Coquard, I.; Oaknin, A.; Gonzalez-Martin, A.; Hasegawa, K.; Corr, B.; more...
    Journal of the National Comprehensive Cancer Network (2025)

    Fulltext@MSK | Save
  • Immune checkpoint blockade response in mucinous tubular and spindle cell carcinoma
    Journal Article

    Makker, S.; Shah, N. J.; Carlo, M. I.; Kuo, F.; Hakimi, A. A.; Chen, Y. B.; Iyer, G.; Kotecha, R. R.
    Current Oncology (2025)

    Fulltext@MSK | Save
  • Clinical outcomes by baseline metastases in patients with renal cell carcinoma treated with lenvatinib plus pembrolizumab versus sunitinib: Post hoc analysis of the CLEAR trial
    Journal Article

    Grünwald, V.; McKay, R. R.; Buchler, T.; Eto, M.; Park, S. H.; Takagi, T.; Zanetta, S.; Keizman, D.; Suárez, C.; Négrier, S.; more...
    International Journal of Cancer (2025)

    Fulltext@MSK | Save
  • Targeting ataxia telangiectasia-mutated and Rad3-related for anaplastic thyroid cancer
    Journal Article

    Lin, S. F.; Hsueh, C.; Chen, W. Y.; Chou, T. C.; Wong, R. J.
    Cancers (2025)

    Fulltext@MSK | Save
  • First and second-line treatments in metastatic renal cell carcinoma
    Review

    Barragan-Carrillo, R.; Saad, E.; Saliby, R. M.; Sun, M.; Albiges, L.; Bex, A.; Heng, D.; Mejean, A.; Motzer, R. J.; Plimack, E. R.; more...
    European Urology (2025)

    Fulltext@MSK | Save
  • Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment
    Journal Article

    Smith, E. A.; Belote, R. L.; Cruz, N. M.; Moustafa, T. E.; Becker, C. A.; Jiang, A.; Alizada, S.; Prokofyeva, A.; Chan, T. Y.; Seasor, T. A.; more...
    Journal of Experimental and Clinical Cancer Research (2024)

    Fulltext@MSK | Save